Isabelle Opitz

11.4k total citations
249 papers, 3.7k citations indexed

About

Isabelle Opitz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Isabelle Opitz has authored 249 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Pulmonary and Respiratory Medicine, 59 papers in Surgery and 39 papers in Oncology. Recurrent topics in Isabelle Opitz's work include Occupational and environmental lung diseases (96 papers), Pleural and Pulmonary Diseases (82 papers) and Lung Cancer Diagnosis and Treatment (44 papers). Isabelle Opitz is often cited by papers focused on Occupational and environmental lung diseases (96 papers), Pleural and Pulmonary Diseases (82 papers) and Lung Cancer Diagnosis and Treatment (44 papers). Isabelle Opitz collaborates with scholars based in Switzerland, United States and United Kingdom. Isabelle Opitz's co-authors include Walter Weder, Rolf A. Stahel, İlhan İnci, Emanuela Felley‐Bosco, Didier Schneiter, Thomas Kocher, Urs Giger, Alex Soltermann, Thomas Frauenfelder and Sven Hillinger and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Isabelle Opitz

224 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Opitz Switzerland 32 2.5k 826 631 507 431 249 3.7k
John C. Kucharczuk United States 32 2.1k 0.9× 1.7k 2.0× 565 0.9× 546 1.1× 473 1.1× 108 3.8k
Françoise Le Pimpec‐Barthes France 39 3.0k 1.2× 1.3k 1.6× 1.2k 2.0× 306 0.6× 370 0.9× 246 4.6k
Franco Orsi Italy 25 1.1k 0.4× 672 0.8× 673 1.1× 455 0.9× 377 0.9× 98 2.6k
Vladimir Mouraviev United States 35 2.0k 0.8× 849 1.0× 296 0.5× 383 0.8× 563 1.3× 148 3.1k
Noriyoshi Sawabata Japan 34 2.6k 1.0× 786 1.0× 1.1k 1.8× 379 0.7× 340 0.8× 180 3.7k
Edouard J. Trabulsi United States 33 2.3k 0.9× 1.3k 1.6× 841 1.3× 477 0.9× 552 1.3× 201 4.0k
Brian C. McCaughan Australia 37 2.8k 1.1× 818 1.0× 1.2k 2.0× 467 0.9× 851 2.0× 121 4.5k
Philippe Astoul France 30 3.0k 1.2× 800 1.0× 388 0.6× 279 0.6× 211 0.5× 177 3.5k
Andreas Schuck Germany 25 1.8k 0.7× 615 0.7× 446 0.7× 539 1.1× 458 1.1× 63 2.7k
Otto M. van Delden Netherlands 34 1.6k 0.6× 2.4k 2.9× 1.3k 2.0× 393 0.8× 206 0.5× 145 4.0k

Countries citing papers authored by Isabelle Opitz

Since Specialization
Citations

This map shows the geographic impact of Isabelle Opitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Opitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Opitz more than expected).

Fields of papers citing papers by Isabelle Opitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Opitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Opitz. The network helps show where Isabelle Opitz may publish in the future.

Co-authorship network of co-authors of Isabelle Opitz

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Opitz. A scholar is included among the top collaborators of Isabelle Opitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Opitz. Isabelle Opitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Láng, György, et al.. (2024). Flow Controlled Ventilation: A Promising Ventilation Strategy for Single Lung Transplantation. The Journal of Heart and Lung Transplantation. 43(4). S345–S346.
3.
Guglielmetti, Laura C., et al.. (2024). Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis. European Journal of Cardio-Thoracic Surgery. 65(4). 1 indexed citations
4.
Werner, Raphael S., Markus Rechsteiner, Holger Moch, et al.. (2024). Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases. European Journal of Cardio-Thoracic Surgery. 65(6). 1 indexed citations
5.
Vrugt, Bart, Michaela B. Kirschner, Mayura Meerang, et al.. (2023). Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma. Cancers. 15(20). 4978–4978. 14 indexed citations
6.
Houda, Ilias, Idris Bahce, Chris Dickhoff, et al.. (2023). OA06.03 An International EORTC Survey on Resectability of Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 18(11). S55–S56. 8 indexed citations
7.
Hiltbrunner, Stefanie, Lena Cords, Sandra N. Freiberger, et al.. (2023). Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype. Nature Communications. 14(1). 5154–5154. 30 indexed citations
8.
Faccioli, Eleonora, Giulia Lorenzoni, Didier Schneiter, et al.. (2023). Validated Prognostic Scores to Predict Outcomes in ECLS-Bridged Patients to Lung Transplantation. Transplant International. 36. 11609–11609.
9.
Moch, Holger, Luca Regli, Émilie Le Rhun, et al.. (2023). OA18.05 Tumor Immune Microenvironment Profiling in Oligometastatic Non-Small Cell Lung Cancer with Brain Metastases. Journal of Thoracic Oncology. 18(11). S86–S87.
10.
Mayer, Laura, Simon Schneider, Esther I. Schwarz, et al.. (2023). Change in Right-to-Left Shunt Fraction in Patients with Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Endarterectomy. Journal of Cardiovascular Development and Disease. 10(11). 442–442. 1 indexed citations
11.
Kirschner, Michaela B., et al.. (2023). Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma. International Journal of Molecular Sciences. 24(17). 13410–13410. 2 indexed citations
12.
Kirschner, Michaela B., Lennart Opitz, Linda Grob, et al.. (2023). Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing. Cancers. 15(10). 2813–2813. 1 indexed citations
13.
González, Michel, Herbert Decaluwé, Clemens Aigner, et al.. (2022). Sleeve lobectomy in patients with non-small-cell lung cancer: a report from the European Society of Thoracic Surgery database 2021. European Journal of Cardio-Thoracic Surgery. 62(6). 7 indexed citations
14.
Furrer, Katarzyna, Daniel P. Dolan, Alessandra Curioni‐Fontecedro, et al.. (2021). Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes. European Journal of Cardio-Thoracic Surgery. 60(6). 1297–1305. 12 indexed citations
15.
Caviezel, Claudio, Henrik Jessen Hansen, Michael Perch, et al.. (2020). Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves. Interactive Cardiovascular and Thoracic Surgery. 32(2). 263–269. 5 indexed citations
16.
Lara, Paulino Tallón de, Virginia Cecconi, Stefanie Hiltbrunner, et al.. (2018). Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients. Clinical Cancer Research. 24(24). 6345–6354. 44 indexed citations
17.
Klikovits, Thomas, Paul Stockhammer, Viktória László, et al.. (2017). Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific Reports. 7(1). 16456–16456. 20 indexed citations
18.
Wu, Licun, Ghassan Allo, Thomas John, et al.. (2016). Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma. Clinical Cancer Research. 23(4). 1060–1067. 40 indexed citations
19.
Meerang, Mayura, Emanuela Felley‐Bosco, Olivia Lauk, et al.. (2016). Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma. Molecular Cancer Therapeutics. 15(5). 1095–1105. 21 indexed citations
20.
Opitz, Isabelle, Alex Soltermann, Hubert Rehrauer, et al.. (2012). Role of Hedgehog Signaling in Malignant Pleural Mesothelioma. Clinical Cancer Research. 18(17). 4646–4656. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026